SB756050

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB756050, covering 2017-07-13 to 2017-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing. [Phase 1]